The company was founded in 2005 and is the first listed company in the field of pathological diagnosis in China. It integrates R&D, production, marketing, service and education, and has built four major businesses: tumor screening, tumor diagnosis, digital pathology, and pathology services. The company has independently developed a series of tumor screening and diagnostic reagents, automated equipment and artificial intelligence software for auxiliary diagnosis. The main application department is the Department of Pathology. The main products are in vitro diagnostic reagents and diagnostic instruments. Company honors: Municipal Industrial Design Center, High-tech Enterprise, Guangzhou Clean Production Enterprise, etc.